Top compounds associated with response to C18orf63


Feature Type Standardized
Nominal ANOVA
mRNA rigosertib CTRPv2 pan-cancer AAC 0.023 0.5
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA regorafenib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC 0.021 0.5
mRNA VU0155056 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA WP1130 CTRPv2 pan-cancer AAC 0.024 0.5
Download CSV